Daylight Eye Exposure — Body Handbook

Light · §473

Daylight Eye Exposure

Modern indoor life is a low-grade light deficiency. A bright office hits 500 lux; an overcast sidewalk hits 10,000; midday sun hits 100,000. The eye and the brain treat those as different inputs — and the deficit shows up as later sleep, foggier afternoons, lower mood, and in children, a global epidemic of nearsightedness. Going outside is the correction. Twenty to forty minutes a day — ideally in the morning, sunglasses optional — covers most of the gain.

Do · Daily Evidence Moderate Chapter Light

The biggest free everyday-wellness lever most adults are missing. Morning daylight is the strongest single input for falling asleep faster, waking up clearer, and lifting low mood — researchers have measured serotonin rising directly with sunshine hours. For kids it's something else: the only thing shown in multiple trials to prevent nearsightedness. The catch is the dose. Standing near a window or walking the dog under a hood doesn't do it; you need actual sky overhead.

The simple story: your eye is a light meter wired to the rest of your body. Two specific signals matter — one for setting the body clock, one for keeping a child's eye the right shape.

For the body clock, a small subset of cells in the retina (the ones with a pigment called melanopsin) feed straight into the brain's master clock. They don't care about images; they care about brightness. When those cells fire hard in the morning, the clock tightens up: melatonin shuts off cleanly, the cortisol wake-up signal lands on time, and the same clock fires bedtime hormones earlier that evening. Indoor light at 300–500 lux barely budges them. Outdoor light at 10,000+ lux drives them flat-out.

For nearsightedness, the relevant signal is retinal dopamine. Bright light hitting the retina releases dopamine, and dopamine tells the eye to stop elongating — the elongation that produces nearsightedness. The relationship is dose-dependent and well-mapped in animals: brighter light, more dopamine, less axial growth (Feldkaemper & Schaeffel 2013). Indoor light is not bright enough to drive this signal meaningfully; outdoor light is.

Two systems, one input. That's why "go outside" keeps showing up across very different research literatures.

What the trials actually show

This is one of the better-evidenced "lifestyle" interventions in the book. Three different bodies of research — myopia trials, circadian camping studies, and a 400,000-person mood cohort — point the same direction.

The catch: outdoor time prevents kids from becoming nearsighted. It doesn't reliably slow progression once they already are (Xiong et al. 2017). The dopamine signal seems to act on the developing eye, not the already-elongated one. For a child still seeing 20/20, it's prevention. For one already in glasses, atropine eye drops plus outdoor time is what Asian myopia clinics now do.

For the body clock, the cleanest evidence comes from camping studies. Take a group of average people, send them into the wilderness with no electric light for a week, and their internal clocks shift earlier by about two hours (Wright et al. 2013). The effect holds in winter, with only nine hours of daylight, and even one weekend outdoors closes half the phase gap that modern life pushes (Stothard et al. 2017).

For mood, the strongest single dataset is the UK Biobank. Across 400,000 adults, each additional hour of outdoor time per day predicted less frequent low mood, less antidepressant use, and shorter time-to-sleep — and the longitudinal design rules out the obvious "depressed people stay inside" reverse-causation read (Burns et al. 2021). The mechanism is partly circadian and partly direct: jugular-vein sampling shows that brain serotonin production tracks how many hours of bright sunshine the day had (Lambert et al. 2002). Sunny day in, more serotonin out. Light-therapy boxes — the indoor version of the same idea, 10,000 lux for half an hour — match antidepressants for seasonal depression in head-to-head trials (Golden et al. 2005).

If you have kids

This is the section that matters most. Childhood nearsightedness used to be uncommon; in urban East Asia it's now over 80% of young adults, and the global projection has half the world's population nearsighted by 2050. The single best predictor in cross-population data isn't screens or near-work — it's how many hours a day kids spend outdoors. Australian-born children of East Asian descent show roughly half the myopia rate of their cousins in Singapore, on the same genes and similar screen habits, mostly because they get more outdoor time (Rose et al. 2008).

The trial-tested floor is 40 minutes a day; the prevalence curve in cohort data flattens around 2 hours (He et al. 2015), (Rose et al. 2008). Sports vs walking vs unstructured play didn't matter in the trials — the variable is light hitting the retina, not the activity. Recess outside, walked school commute, weekend park time all count. Window-side homework doesn't.

How much, and when

The biological signal saturates fast. You don't need an hour; you don't need direct sun. Overcast outdoor light at ~10,000 lux is already a couple of magnitudes above any indoor space. Timing is the lever that compounds the rest.

Morning anchor (adults): 10–30 minutes outside within an hour of waking. Coffee on a balcony, walk to the bus stop the long way, breakfast on a porch. This is the single highest-leverage piece — it sets the day's clock.
Cumulative daily target: 30–40 minutes most days for adults; 40 minutes minimum for kids of school age, ideally more. Outdoor lunch break, a 15-minute afternoon walk, time at a park with kids — they all add up.
Sunglasses: Off in the first hour of morning light (the dose is the point). On in midday sun or any high-UV setting — beach, snow, water, mountains, low latitudes. Sunglasses don't kill the circadian signal; outdoor light through dark lenses still beats indoor light by 10×.
Open sky beats shaded outdoor. Under a tree or an awning is intermediate — better than indoors, but the dose is roughly halved. Standing in the open delivers the full signal.

If your job is desk-to-desk, the practical move is to treat morning daylight like brushing your teeth — a non-optional first-twenty-minutes-of-the-day thing. Lunch outside is the second-largest lever. The afternoon dip people patch with caffeine is partly a daylight problem.

What most people get wrong

"My office has big windows — that counts." Window glass cuts outdoor light by roughly 10×, and it strips the short wavelengths that drive part of the biology. A "bright" window seat is usually 1,000–3,000 lux. That's better than a back-office cubicle, but it's still 5–50× below what your eyes see outside, and the myopia trials specifically measured time outdoors, not "near a window." If you can't see your own shadow on the floor, the dose is too low.

"I get enough light at home/at work." Modern offices target around 500 lux at desk height; even premium "circadian lighting" installs rarely clear 1,500. The gap to outdoors is one to two orders of magnitude (Wright et al. 2013). Indoor light is for vision, not for biology.

"Sunglasses kill the benefit." Standard sunglasses transmit 5–25% of incident light. Outdoor light through sunglasses is still 500–25,000 lux — well above your living room. The myopia trials didn't control for sunglasses use and still showed the effect. Wear them when the sun is harsh.

"Screens are why kids are nearsighted." Near-work correlates with nearsightedness, but when researchers control for both, time outdoors is the stronger and independent predictor (Rose et al. 2008). Kids who do lots of homework and lots of outdoor time have lower rates than kids who do less of both. The protective factor is light, not the absence of screens.

"Weekends will catch me up." Two long outdoor weekend days do not replace five missed weekday mornings. The body clock is set by the daily signal, not the weekly total (Stothard et al. 2017).

When to be careful

The dominant risk for everyone else isn't the eye exposure itself — it's cumulative UV. Decades of unprotected outdoor work raises the risk of pterygium (a fleshy growth on the white of the eye), cataract, and surface scarring; outdoor workers in tropical and high-altitude settings carry odds ratios of 2 to 7× for pterygium compared with indoor workers (Modenese & Gobba 2018). UV-blocking sunglasses and a brimmed hat for sustained midday exposure handle this cleanly.

How this goes wrong in practice

The classic "I tried it, didn't notice anything" stories usually trace to the same handful of mistakes.

Sub-threshold dose dressed up as enough. Walking to a coffee shop with a hood up and sunglasses, indoors in three minutes — that's a vibes-of-outside, not the input. The retina has to see open sky for several minutes for the signal to register.
Wrong time of day. An hour of bright outdoor light at 5 p.m. helps mood but does much less for sleep than 15 minutes at 7 a.m. The clock-anchoring signal is strongest in the morning.
Tree-cover or awning all the time. Outdoor shade is intermediate — useful but not the same dose. Stepping out into open sky for even a minute or two raises the average meaningfully.
Kids "outside" but inside. "Outdoor recess" that ends up under a covered breezeway is not the dose the trials tested. Open playground area is what produced the myopia signal.
Northern winters. December at 55°N gives few morning daylight hours and overcast light may dip to 1,000 lux. The outdoor dose is real but smaller; a 10,000-lux lightbox indoors becomes a reasonable supplement, not a gimmick.
Confusing outdoor exposure with cardio. The intervention is light. You don't have to exercise. Stationary outdoor time — a coffee on the front step — counts.

What you're trading for staying in

The shape of the deficit is slow and unspectacular. You don't notice the day you stopped getting morning light — you notice, weeks later, that you've started "needing" two coffees, that the 3 p.m. wall is heavier, that bedtime keeps creeping later and the alarm keeps feeling crueller. Friends ask if you've been sleeping. Your partner notices you snap easier on Sundays. You start thinking of yourself as a "not a morning person." Most of that is fixable.

Across 400,000 adults in the UK, the bottom tertile of outdoor-light exposure had measurably higher antidepressant use and more frequent low-mood episodes than the top tertile — after controlling for age, income, work, and sleep duration (Burns et al. 2021). The effect on any one person is small. The cost to a life lived indoors for a decade is not small.

For children, the stakes are sharper. The countries where kids spend the least time outdoors have already produced young adults who are 80%+ nearsighted, with the highest-risk children heading toward high myopia — the kind that brings real lifelong consequences (retinal detachment, glaucoma, macular damage). The window for prevention closes around the early teens, when the eye stops growing. A childhood spent indoors trades adult eye health for elementary-school convenience.

What changes if you do this

The fastest signal is sleep. Within a week of consistent morning outdoor light, most people fall asleep earlier without trying — the body starts releasing melatonin closer to a sane bedtime, the alarm becomes less of a fight, and the morning fog clears faster (Wright et al. 2013). People around you notice second: the partner who used to wait an extra forty minutes for you to be human stops having to.

By week two or three, the mood floor lifts. This is the channel where the light-therapy trials show effect sizes equal to antidepressants for seasonal depression (Golden et al. 2005). It's not a euphoria — it's that a normal Tuesday stops feeling vaguely difficult. The afternoon dip you fought with caffeine softens; the meeting you used to dread goes differently because you walked to it across a sunlit street.

On the year scale, the gains are cumulative and quiet. A more consistent sleep window. Fewer "low weeks." For children, the payoff isn't felt at all — it's the absence of an outcome. The 9-year-old who'd otherwise be in glasses by 12 isn't, and neither is the 16-year-old who'd be in stronger ones (He et al. 2015), (Cao et al. 2020). The forecast for the adult version of that child is straight eyesight into late life, without the trajectory toward high-myopia complications.

Vitamin D works through the skin, not the eye — a separate intervention with its own dose-response and trade-offs. Skin sun exposure raises tanning, photoaging, and skin-cancer questions that don't apply to eye-route daylight. Evening light hygiene (dimming the house after sunset, avoiding bright screens late) is the bookend to this entry: morning brightness and evening darkness work as a pair. For people stuck indoors in northern winters, 10,000-lux light therapy boxes are the legitimate proxy. And if your sleep stays bad despite a year of morning sun, the next thing to look at is your airway, not your light.

Related in the handbook

Helps

— Morning light pulls your body clock earlier, so you fall asleep sooner that night.
— For seasonal low mood, real outdoor daylight does much of what a light box does — and it's free.
— Morning daylight sets the clock that decides when you'll feel sleepy tonight.

— Getting your daily outdoor light dose first thing in the morning is the highest-value slot of all for your body clock.
— Pair bright mornings outdoors with dim, warm light at night for the cleanest circadian signal.
— Bright by day, dark by night — the two halves of the same circadian signal.
— Getting outside for the light dose usually means getting outside among trees — the nature exposure stacks its own stress-hormone drop on top.
— The same outdoor time that fixes your light deficiency also makes vitamin D, but only in summer sun; in winter at high latitude that channel shuts off.

Substance and claimed effects

The substance is daylight reaching the eyes — the photic input the retina gets from being outdoors under sky, distinct from indoor electric lighting. Typical illuminance gap: well-lit office ≈ 300–500 lux; overcast outdoor ≈ 10,000 lux; direct sun ≈ 50,000–100,000 lux (Wright 2013, Cajochen 2000). The same number of "hours of light" indoors and outdoors are not the same biological input.

Claimed effects, all in scope for this entry: (1) slowed myopia onset and progression in children; (2) reduced ocular-surface strain and dry-eye symptoms in screen-heavy adults, balanced against cumulative UV-mediated ocular surface damage (pterygium, photokeratitis, lens opacities); (3) circadian phase anchoring via ipRGC → SCN signalling, with downstream effects on sleep onset, sleep depth, and daytime alertness; (4) improved mood and lower depression incidence, including but not limited to seasonal affective disorder. Vitamin D synthesis is excluded — it operates through the skin, not the eye, and warrants its own entry.

Evidence by addressing question

mechanism

Science / mechanism — myopia. Animal and human work converges on a retinal dopamine model: bright light activates retinal dopamine release; dopamine acts via D2-like receptors on inner-retinal circuits to suppress axial elongation of the eye (Feldkaemper & Schaeffel 2013). Form-deprivation myopia in chicks and primates is blunted by dopamine agonists and worsened by antagonists; the dose-response between retinal illuminance and dopamine is log-linear. The implication: indoor light (100–500 lux) sits orders of magnitude below the levels at which retinal dopamine release plateaus. Spectral content (UV/violet) may contribute via OPN5 photoreceptors, but the dominant signal in human data is intensity, not wavelength.

Science / mechanism — circadian. Intrinsically photosensitive retinal ganglion cells (ipRGCs), containing melanopsin, project to the suprachiasmatic nucleus and entrain the master clock. The system is dose-responsive: dim light (<30 lux) gives <50% melatonin suppression at night in most people but >300 lux saturates the alerting response by day (Cajochen 2000, Phillips 2019). Morning daylight advances the phase of the SCN, compressing the gap between sleep onset and "biological night start." Camping studies in real wilderness conditions collapse circadian phase by ~2 hours within a week (Wright 2013, Stothard 2017).

Science / mechanism — mood. Two mechanisms operate in parallel. (1) Circadian: phase-advanced, higher-amplitude rhythms correlate with lower depression scores; daytime light raises rhythm amplitude. (2) Direct neurochemical: jugular-vein sampling shows that brain serotonin turnover rises with prevailing bright-sunlight duration (Lambert 2002). Light therapy at 10,000 lux for ~30 min/day clinically replicates this — effect sizes for seasonal and non-seasonal depression match SSRIs in head-to-head trials (Golden 2005).

Mechanism — ocular surface. Indoor near-work and screen use depress blink rate from ~15/min to ~5/min, drying the tear film. Going outdoors typically displaces near-work and resets blink behaviour. Counter-mechanism: UV-B exposure damages limbal stem cells and conjunctival fibroblasts, driving pterygium and pinguecula formation over decades; reflected UV from snow, water, sand amplifies this (Modenese & Gobba 2018). The net effect on the ocular surface depends on UV protection: outdoor time with brimmed hat / sunglasses is net-positive; equivalent time without protection in high-UV settings is net-negative for the surface, though still positive for the retinal-dopamine and circadian channels.

evidence

Myopia — RCT evidence. Three completed randomized trials in children. Wu 2013: Taiwan, two suburban schools, ~570 children 7–11; the intervention school required outdoor recess. Over 1 year, new-myopia incidence was 8.4% in the intervention school vs 17.6% in control. He 2015: Guangzhou, cluster-RCT of 1,903 first-graders across 12 schools; one extra 40-min outdoor class daily for 3 years. Cumulative new-myopia incidence 30.4% (intervention) vs 39.5% (control), absolute risk reduction 9.1% (95% CI 4.1–14.1, p<.001). Cao 2020 pooled 5 RCTs (n = 3,014): risk ratio for new myopia 0.76 (95% CI 0.67–0.87), axial-length progression reduced 0.03 mm/year, I²=0% (rare for myopia literature). The Sydney Myopia Study (Rose 2008) found that 6- and 12-year-olds doing >2 h/day outdoors had myopia prevalence roughly half that of children doing <1 h/day, independent of near-work hours. Meta-analysis dose-response: each additional hour outdoors per week → ~2% reduced odds of myopia (Xiong 2017). Trial intensity threshold appears to be cumulative — most interventions tested ≥40 min/day, no trial tested <30 min.

Myopia — caveat on progression vs onset. The cleanest signal is on onset. Xiong 2017 reports outdoor time does not slow progression in already-myopic children — the dopamine signal appears to act on the emmetropization window, not on established axial elongation. Practical reading: outdoor time prevents children from becoming myopic; for kids already in glasses, atropine + outdoor time is the protocol now used in Asian myopia clinics.

Circadian — entrainment evidence. Wright 2013 measured dim-light melatonin onset (DLMO) before and after a week of camping (no electric light); DLMO advanced ~2 hours, sleep timing followed. Stothard 2017 replicated in winter (9 h:14 h day:night) and showed weekend camping alone collapses half the phase delay from modern life. UK Biobank free-living data: each additional hour outdoors per day → earlier chronotype, shorter sleep latency, fewer reported "insomnia symptoms" (Burns 2021, n>400,000).

Mood — observational + RCT. Burns UK Biobank: each additional hour of outdoor time → reduced incidence of "feeling down", lower antidepressant use, higher self-rated happiness; the longitudinal cross-lagged design rules out reverse causation (more depressed people staying indoors) as the sole driver (Burns 2021). Light-therapy RCTs (10,000 lux box, ~30 min) for SAD and non-seasonal depression: pooled effect size ~0.84 for SAD, ~0.53 for non-seasonal depression — equivalent to antidepressant pharmacotherapy (Golden 2005). The light-therapy literature is the strongest indirect evidence for outdoor daylight's mood effect; the only difference is delivery format.

Ocular surface — observational. No RCTs on outdoor time and dry eye specifically; the evidence is mechanistic (blink rate physiology). For UV-driven surface disease, Modenese & Gobba's systematic review of 29 studies (2008–2018): outdoor workers have OR 2–7 for pterygium depending on latitude; WHO attributes 42–74% of pterygium burden to solar UV (Modenese & Gobba 2018). Cataract and age-related macular degeneration have weaker but consistent UV-exposure associations.

protocol

Effective doses derived from trial evidence and circadian dose-response:

Children (myopia): ≥40 minutes of outdoor time daily (school + post-school) is the trial-tested floor that delivers a 9% absolute risk reduction over 3 years (He 2015). The Sydney data suggests 2 hours/day is where the prevalence curve flattens (Rose 2008). Outdoor time is what matters; sports vs unstructured play vs walking school commute appear equivalent — the variable is retinal illuminance, not activity type.
Adults (circadian): ≥10–30 minutes of morning outdoor light, within ~1 hour of waking, drives the largest phase-anchoring signal (Wright 2013). Overcast outdoor light (~10,000 lux) is sufficient — sunlight is not required. The dose for alerting saturates around ~1,000 lux during the day (Cajochen 2000), so any meaningful outdoor exposure exceeds it.
Adults (mood): The light-therapy analogue is 10,000 lux for 30 minutes (Golden 2005). Overcast outdoor matches this; mid-day sun delivers it in <5 minutes. Each additional hour outdoors/day in UK Biobank → small but real reduction in depressed-mood symptoms (Burns 2021).
UV protection: Brimmed hat and UV-blocking sunglasses for any sun exposure beyond ~30 minutes; mandatory for snow, water, high-altitude, or low-latitude environments. Sunglasses do not block enough light to defeat the circadian or dopamine signal — retinal illuminance through standard sunglasses outdoors still vastly exceeds indoor levels.

contraindications

Few. Photic-sensitive epilepsy and photosensitive lupus / xeroderma pigmentosum need clinician input. Lens-replacement surgery patients without UV-filtering implants should be cautious with direct mid-day sun. Otherwise universally indicated — the population deficit is overwhelmingly under-exposure, not over-exposure.

misconceptions

(1) "Sitting by a window counts." Window glass attenuates outdoor illuminance roughly 10×; a "bright" window seat is typically 1,000–3,000 lux vs 10,000+ outdoors. Glass also blocks most UV-B, which removes the spectral component that drives some of the dopamine signal in animal models. The myopia trials specifically measured time outdoors, not "near a window." (2) "Indoor lighting is enough — modern offices are bright." Modern office design targets ~500 lux at desk height; even a daylight-balanced "circadian lighting" install rarely exceeds 1,500 lux. The biological gap to outdoors is 1–2 orders of magnitude (Wright 2013). (3) "Sunglasses cancel the benefit." Standard sunglasses transmit 5–25% of incident light. Outdoor light through sunglasses is still 500–25,000 lux — above the indoor baseline. The myopia trials did not control sunglasses use and saw the effect anyway. (4) "Screen time is the cause of myopia." Near-work correlates with myopia but in multivariate models, outdoor time is the stronger and independent predictor (Rose 2008). Children who do lots of near-work AND lots of outdoor time have lower myopia than children who do less of both.

audience

Children (≤14): Myopia channel dominates. Asian-ethnicity children are the worst-affected population — myopia prevalence in urban East Asia exceeds 80% in young adults, vs ~40% in equivalent Australian-of-East-Asian-descent samples, the gap attributed largely to differing childhood outdoor time (Rose 2008). Trial-grade evidence is densest here.

Adults (18–59): Circadian + mood + alertness channels dominate; ocular-surface channel relevant for screen workers. Daylight competes with the work pattern of most knowledge workers, which is the practical bottleneck.

Older adults (60+): Same circadian + mood gains, plus lens-aging means less UV reaches the retina, which means a higher outdoor dose may be needed for the same biological effect. UV protection becomes more important because lens opacities accumulate; cataract risk rises with cumulative ocular UV.

Night-shift workers: Outdoor light timing inverts. Morning outdoor light after a night shift will keep them entrained to a day schedule they don't live; targeted bright light during the work shift and dark sunglasses on the commute home are the protocol — see chronobiology references, outside this entry's primary scope.

failure-modes

(1) Walking the dog at 7am with sunglasses + hood up. The intent is right but the retinal dose is much lower than the user thinks. (2) Reading near a window for an hour. Lux through glass is far short of trial-tested doses. (3) "I get outside on weekends." Two big weekend doses cannot replace weekday entrainment — the SCN is anchored by the daily light signal, not weekly totals (Stothard 2017). (4) Excessive UV without protection. Pterygium, photokeratitis ("snow blindness"), accelerated cataract — visible at tropical-latitude outdoor workers. (5) Children sent outside but staying under a covered awning. Shaded outdoor is intermediate (~5,000 lux) — better than indoors but lower-dose than open sky.

stakes

Stakes evidence comes from inversion of the same data. UK Biobank shows that the lowest tertile of outdoor-time exposure has 13% higher odds of "frequent feelings of being down" and 17% higher use of antidepressants vs the highest tertile, after adjustment for age, sex, socioeconomic status, employment, and sleep duration (Burns 2021). The myopia epidemic in urban East Asia — projected 50% of world population myopic by 2050 — is the macroscopic stakes case for the child population.

payoff

Sleep-onset latency, sleep-depth, and self-rated mood are the fastest channels (days to a week, consistent with circadian phase-anchoring time constants — Wright 2013, Stothard 2017). Mood lift from light therapy stabilises by week 2–3 (Golden 2005). Myopia delay shows over years, not months — visible only in cohort comparisons. Cumulative-aesthetic gains (less screen-strain redness, fewer dark-circle markers from poor sleep) ride on the sleep and mood improvements; they are second-order and modest.

out-of-scope

Vitamin D synthesis (skin, not eye — separate entry); skin-mediated dermatological effects of UV (tanning, photoaging, skin cancer); the broader argument for time-in-nature beyond light specifically (green-space and stress, microbiome diversity from outdoor environments); seasonal affective disorder treatment specifically (own entry would be warranted); light-therapy boxes as an indoor proxy.

Credibility range

Optimist case. The myopia RCT evidence is rare in lifestyle medicine: multiple trials, consistent direction, dose-response, mechanism (dopamine) validated in animal models, meta-analysis with I²=0%. The circadian evidence is similarly tight — camping studies are essentially within-subject experiments showing the natural light-dark cycle resets the clock. UK Biobank gives 400,000-person longitudinal mood data with cross-lagged design controlling reverse causation. Pull these together and the case is: indoor-only modern life is a chronic, population-scale photic deficiency, and reversing it is one of the highest-leverage zero-cost interventions in the catalogue.

Skeptic case. The myopia mechanism question is unsettled — the dopamine model fits animal data but human ipRGC/dopamine pathways are inferred, not directly measured. Outdoor time confounds with physical activity, near-work reduction, social interaction, and vitamin D; isolating "eye-light" from these in observational data is hard, and the RCTs intervened on the bundle, not the photons. UK Biobank effect sizes for mood are small (odds-ratio differences of 1.1–1.2), and self-reported outdoor time is noisy. The light-therapy RCTs use 10,000-lux boxes for 30 min, which is a much more controlled exposure than "go outside for a walk" — generalisation is plausible, not proven. Pterygium and lens damage are real cumulative costs that the optimist case underweights.

Author's call. The intervention is real, the direction is robust, the magnitude is moderate-to-large for circadian and myopia, moderate for mood, and the cost is zero. Even granting the skeptic's confounds, the floor on benefit (circadian phase anchoring, dopamine signal in children) is well-supported and the ceiling on harm with sane UV protection is low. The right framing is not "miracle cure" — it's "modern indoor life is a deficiency state, and going outdoors is the correction." Evidence rating: 4. Controversy: 1 (low — the field agrees on direction; debates are about magnitude and mechanism specifics).

Stakeholder and incentive map

Pushing the intervention: Pediatric ophthalmology (myopia epidemic is the field's defining public-health crisis); circadian researchers and the broader light-and-health consortium (CIE, DIN, IES committees publishing new daylight-design standards); chronobiology academia (Czeisler, Wright, Cain labs); public-health bodies in East Asia where myopia has reached national-emergency status (Taiwan, Singapore, China school-recess mandates).
Pushing back / inertia: Commercial real-estate and office-design conventions optimised around artificial-light cost minimisation; screen and tech industries whose product use displaces outdoor time; supplement industry pushing vitamin D and other proxies for "what you'd get outside"; dermatology messaging emphasising sun avoidance for skin cancer prevention (which is correct but creates tension with eye-and-circadian benefits).
Neutral commercial: Lighting industry — the high-end of the market is moving toward "circadian lighting" / "human-centric lighting" but indoor-only systems still fall short of outdoor by 1–2 orders of magnitude, so claims that "our lights replace sunshine" should be discounted.

Population variability

Latitude and season. Winter at high latitudes (Scandinavia, northern Canada) provides few hours of outdoor light and lower midday illuminance — the deficit case is most acute there, and light-therapy box use is most appropriate.
Ethnicity. East Asian children show the highest myopia risk and the largest absolute benefit from outdoor intervention (Rose 2008). Darker iris pigmentation moderately reduces retinal illuminance for the same external lux; effect on dopamine signal is unclear.
Age. Lens yellowing with age reduces short-wavelength light reaching ipRGCs and retinal dopamine cells; older adults may need higher outdoor doses for equivalent circadian or mood effect.
Individual circadian sensitivity. Phillips 2019 found >50-fold interindividual variability in melatonin suppression response to evening light. The same likely applies to daytime phase-anchoring sensitivity: some people will get sleep improvement from a 15-minute morning walk, others need an hour.
Baseline circadian disruption. Shift workers, frequent travellers, depressed patients — these populations are operating with disrupted rhythms and have more to gain from a daily outdoor-light anchor than the already-entrained.

Knowledge gaps

Mechanism of myopia. Dopamine is the leading candidate but precise circuit detail in humans is missing; whether intensity, spectral content, or temporal variability matters most is unsettled.
Adult myopia. Whether adult-onset myopia (progression after age 18) responds to outdoor light remains under-studied. The animal models all use developing eyes.
Minimum effective dose for circadian effects in free-living adults. Most data come from extreme contrasts (camping vs office); the dose-response curve for "30 vs 60 vs 90 min daily" in normal life is sparse.
Long-term mood RCTs. Light therapy is RCT-proven; "go outside more often" RCTs in mood are operationally hard and mostly absent. The mood evidence is observational + analogue.
Net ocular-surface effect. No trial compares "outdoor time with eyewear protection" against "matched indoor time" for dry-eye or surface health.
What would change the call. A failed adult outdoor-light RCT for sleep or mood would lower the rating. A failed long-term myopia follow-up showing rebound (some signal of this in Wu's 4-year follow-up) would soften the child recommendation. Confirmation of an OPN5-mediated, spectrum-specific pathway would change protocol-specific advice but not the directional call.

Scope. Brief named four consequences (myopia, ocular-surface, circadian, mood). All four covered:

Myopia in children — full audience, evidence, payoff coverage. Strongest evidence in the entry.
Circadian rhythm — backbone of mechanism, evidence, protocol, drives the sleep-4 score.
Mood — covered in evidence, stakes, payoff via Burns 2021 + Lambert 2002 + Golden 2005.
Ocular surface health — narrower coverage than the others. Folded into contraindications as the UV-cost side and gestured at in misconceptions. No RCT evidence for outdoor-time → dry-eye relief specifically; the dry-eye mechanism (blink rate) is real but unproven as a daylight-eye-exposure outcome. Resisted padding this into its own addressing section.

Hard scoping calls.

Vitamin D excluded. Skin-route, not eye-route. Different photoreceptor, different organ, different protocol (UV-B vs visible light), different contraindication profile. Belongs in a separate vitamin-d entry. Flagged in out-of-scope.
Evening light hygiene excluded. The dark side of the circadian pair. Phillips 2019 is the load-bearing study there. Should be its own entry — flagged in out-of-scope.
Light-therapy boxes excluded as a primary topic. They are the strongest mood evidence we have, but they're an indoor proxy, not the substance. Used as analogue evidence in the evidence section; mentioned as a winter fallback in failure-modes and out-of-scope. A dedicated light-therapy entry is warranted.
Skin sun exposure / tanning / photoaging excluded. Different substance.

Rating difficulties.

longevity 2 vs 3 was the closest call. The mechanism-to-mortality chain runs through sleep + mood + (in children) myopia complications. Cohort signals exist but are confounded with physical activity and vitamin D. Landed on 2 because outdoor-time RCTs measure proximal endpoints, not mortality.
mood 4 vs 5: the light-therapy evidence (Golden 2005) is RCT-grade and SSRI-equivalent for SAD, which arguably justifies a 5. Landed on 4 because the outdoor-light evidence is largely observational; the box is the controlled proxy. Reserve 5 for entries where direct RCTs on the substance itself match the 5 anchor.
evidence 4: strong RCTs on myopia, controlled experiments on circadian, observational + light-therapy proxy on mood. The mood story is the weakest link; if a large outdoor-time RCT for mood lands, this could move to 5.
beauty_direct scored 0 (rather than 1). Eye-route daylight does not produce a within-days visible-skin effect; the only candidate (less screen-strain redness) is too marginal to score above 0.

Future-link candidates (entries not yet in the catalogue that this entry should cross-link once they exist).

vitamin-d — skin-route sun + supplementation
evening-light-hygiene or dark-bedroom — the circadian bookend
light-therapy-box — winter and indoor-bound fallback
myopia-management — for already-myopic children: atropine, orthokeratology, multifocal lenses
shift-work-and-circadian — population for whom standard "morning outdoor light" advice is wrong

Separate-entry candidates surfaced while writing. Seasonal affective disorder treatment specifically (light-therapy protocol, dawn simulation, comparison with SSRIs) is substantial enough to deserve its own entry rather than living as a paragraph here.